Insider Trading26 Jun 2026, 12:17 pm
GlaxoSmithKline Pharmaceuticals Ltd: Trading Window Closure for Q1 FY27 Results
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd has announced the closure of its trading window for buying or selling company shares. This closure is effective from Wednesday, July 1, 2026, and will remain in effect until 48 hours after the announcement of the Un-audited Financial Results for the first quarter ended June 30, 2026. The specific date for the Board Meeting to declare these results will be communicated in due course. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent potential insider trading activities.
Key Highlights
- Trading window closed from July 1, 2026, for Q1 FY27 results.
- Closure lasts until 48 hours post-results announcement.
- Aims to prevent insider trading as per SEBI regulations.
- Board meeting date for results declaration to be announced later.
Price Impact
More from GLAXO